Market Value: P&G held a market capitalization exceeding 300 billion dollars during the Fish tenure (Source: Paragraph 4).
Category Concentration: 10 core categories generating the vast majority of profit (Source: Paragraph 8).
2. Operational Facts
Innovation Structure: Shifted from a centralized Corporate R&D model to a decentralized structure where 10 business units own their R&D budgets (Source: Paragraph 12).
Growth Board: Established a senior leadership group including the CEO, CFO, and CTO to govern high-risk, high-reward projects (Source: Paragraph 22).
Growth Works: An internal innovation accelerator designed to apply startup methodologies to large-scale brand building (Source: Paragraph 24).
Staffing: Deployment of 150 Lean Innovation coaches to train brand teams in iterative testing (Source: Paragraph 26).
Cycle Times: Traditional product development took 3 to 5 years; Lean Innovation targets reduced this to months for initial market testing (Source: Paragraph 15).
3. Stakeholder Positions
Kathy Fish (CTO): Advocated for a shift from incremental improvements to irresistible superiority. Believed the existing stage-gate process punished risk-taking (Source: Paragraph 6).
David Taylor (CEO): Supported the cultural shift toward agility and empowered business units to act as small companies (Source: Paragraph 11).
Business Unit Presidents: Initially resistant to R&D budget shifts but eventually incentivized by the speed of the Lean Innovation model (Source: Paragraph 18).
R&D Scientists: Experienced friction moving from long-term technical perfection to rapid, iterative learning cycles (Source: Paragraph 29).
4. Information Gaps
Specific Failure Rates: The case does not provide the exact percentage of Growth Works projects that were terminated versus those that reached national scale.
Competitor R&D Efficiency: Data on the R&D-to-sales ratios of direct competitors like Unilever or specialized D2C startups is absent.
Margin Impact: While revenue growth is noted, the specific impact of Lean Innovation projects on gross margins compared to legacy products is not detailed.
Strategic Analysis: Market Strategy Consultant
1. Core Strategic Question
How can a legacy consumer goods giant institutionalize disruptive innovation without compromising the scale efficiencies that define its competitive advantage?
Can the Lean Startup methodology be successfully transplanted into a 180-year-old corporate culture characterized by risk aversion and rigid hierarchies?
2. Structural Analysis
Jobs-to-be-Done Framework: P&G recognized that consumers were not buying soap; they were buying hygiene and convenience. D2C competitors exploited gaps in the experience (subscription models, personalization). P&G shifted R&D focus from chemical properties to solving consumer friction points.
Value Chain Analysis: The traditional value chain relied on mass media and mass retail. Disruption occurred at the discovery (social media) and delivery (e-commerce) stages. P&G responded by integrating Growth Works to bypass traditional retail bottlenecks during the testing phase.
3. Strategic Options
Option
Rationale
Trade-offs
Institutionalize Lean Innovation
Scale startup agility across all 10 categories using internal coaches.
High cultural resistance; requires significant retraining of R&D staff.
Aggressive M&A Strategy
Acquire successful D2C brands (e.g., Dollar Shave Club model) to buy innovation.
High acquisition premiums; risk of stifling the acquired brand culture.
Spin-off Disruptive Units
Create a separate entity for high-risk projects, isolated from the core.
Loses the benefit of P&G supply chain scale; creates internal silos.
4. Preliminary Recommendation
P&G must pursue Institutionalized Lean Innovation via the Growth Works model. This path allows the firm to maintain its scale advantages in manufacturing and distribution while correcting its primary weakness: speed to market and consumer centricity. The focus on irresistible superiority ensures that innovation is not just different, but demonstrably better, justifying premium pricing in a commoditizing market.
Implementation Roadmap: Operations Specialist
1. Critical Path
Month 1-3: Coach Certification. Finalize the training of the 150 Lean Innovation coaches. These individuals are the operational linchpins who bridge the gap between startup theory and corporate reality.
Month 3-6: Governance Reset. Transition the Growth Board from a quarterly review to a monthly rapid-response funding body. Replace the 150-page stage-gate documents with 5-page learning summaries.
Month 6-12: Pilot Scaling. Move at least two high-potential projects from Growth Works into the core business unit supply chains to test manufacturing elasticity.
2. Key Constraints
The Perfection Trap: P&G R&D culture values 100 percent certainty. Lean Innovation requires shipping at 70 percent certainty. This psychological shift is the primary constraint.
Supply Chain Rigidity: P&G manufacturing plants are optimized for massive runs. Small-batch production for iterative testing creates operational friction and high unit costs in the short term.
Incentive Alignment: If brand managers are still judged on quarterly volume, they will deprioritize long-term disruptive projects that do not contribute to immediate targets.
3. Risk-Adjusted Implementation Strategy
To mitigate execution risk, P&G should utilize external manufacturing partners for the initial testing phases of Growth Works projects. This prevents the disruption of core high-volume plants. Only once a product achieves a 10 percent repeat purchase rate in a test market should it be integrated into the internal P&G global supply chain. This phased approach protects the core while allowing the fringe to move fast.
Executive Review and BLUF
1. BLUF
P&G successfully countered industry disruption by re-engineering its R&D engine from the inside out. By adopting Lean Innovation, the company moved from a slow, risk-averse culture to an iterative, consumer-centric model. This shift was not merely about new products; it was about changing the governance of capital and talent. The Growth Works framework allowed P&G to fail small and scale fast, resulting in the most durable period of organic growth in over a decade. The strategy is sound because it combines startup agility with the unmatched muscularity of the P&G global distribution network.
2. Dangerous Assumption
The analysis assumes that the 10 Business Unit Presidents will remain willing to fund high-risk Growth Works projects during a market downturn. The current success relies on a period of relative stability; a financial crisis would likely see these leaders retreat to the safety of incremental core product updates.
3. Unaddressed Risks
Talent Attrition: Lean coaches and innovators trained at P&G now possess highly marketable skills for startups. There is a high probability that the best internal innovators will leave to start their own companies if the corporate bureaucracy slows down again.
Retailer Backlash: As P&G uses D2C channels to test products, major retail partners like Walmart may view this as a competitive threat, leading to friction in shelf-space negotiations for the core brands.
4. Unconsidered Alternative
The team failed to consider a Reverse Integration Model. Instead of trying to make R&D act like a startup, P&G could have transitioned into a platform company that provides manufacturing and distribution as a service to independent startups in exchange for equity or acquisition rights. This would move the innovation risk entirely off the P&G balance sheet.